ATLANTA, May 1, 2015 /PRNewswire/ -- At the American
Association of Neurological Surgeons (AANS) Annual Meeting,
May 2-6 in Washington D.C., Elekta will highlight Leksell
Gamma Knife® Registry, a solution that enables clinicians to
leverage the enormous amount of data – generated by thousands of
Gamma Knife radiosurgery treatments conducted each year – to
advance clinical research and further optimize patient care.
"Gamma Knife Registry is a cloud-based solution that allows
practitioners to store, retrieve, and analyze Gamma Knife
radiosurgery treatment data*, as well as patient outcomes and
operational information in a common format," says Catherine Gilmore-Lawless, Elekta Vice President, Clinical Intelligence.
"By enabling uniform data entry and indication-specific analysis of
Gamma Knife radiosurgery outcomes, clinicians now have a powerful
tool to expand the use of this proven technology for more
indications."
Currently deployed at several top academic medical centers,
Leksell Gamma Knife Registry aims to:
- Identify global treatment patterns with Leksell Gamma Knife,
and connections between treatment parameters and outcomes
- Provide integrated longitudinal data that could help clinicians
develop insights to better select patients, personalize the
treatment paradigm, and improve quality
- Advance collaboration in clinical research
"As a part of Elekta's Knowledge Management solution, Gamma
Knife Registry is critical to deliver on our vision of
Information-guided care™," says Richard
Stark, Senior Vice President, Elekta
Software. "Gamma Knife Registry allows users to better
aggregate, analyze and gather insights needed to deliver the most
effective and personalized care for each patient. Users can share
their experiences in optimizing Gamma Knife treatments to make
better-informed clinical decisions for their patients' care and
increase quality and efficiency in their practices. The underlying
goal is to drive better patient outcomes."
Leksell Gamma Knife Registry encompasses a secure
HIPAA-compliant data warehouse and advanced indication specific
analytics. Aggregated, de-identified data can be used for studies
undertaken by the global Gamma Knife community. Interactive,
self-service dashboards for visual discovery and reports are
included, in addition to Leksell Gamma Knife® Society statistical
reports.
Collaborative development
Registry development was a
joint effort between Elekta and renowned Gamma Knife centers,
including the University of Pittsburgh
Medical Center, and veteran Gamma Knife radiosurgery practitioners,
notably, Douglas Kondziolka, MD,
Professor of Neurosurgery and Radiation Oncology at New York University School of Medicine.
"Our goal was to create new data sets, specific for Gamma Knife
radiosurgery that are updated continuously and securely over the
web," Dr. Kondziolka says. "This will allow clinicians to obtain
data queries in real time to benchmark their own data with those
nationally or globally. Importantly, underlying these high level
views is a rich database with detailed treatment and follow-up
data, which is ideally suited for research. Imagine basing a study
on not 50 or 100 patients, but 10,000 or 50,000 patients on these
'Big Data' verified data sets. With that kind of powerful
information, we may be able to really effect change in
medicine."
Elekta supports the National SRS Brain Registry, a joint effort
by the American Society for Radiation Oncology (ASTRO) and AANS
which seeks to define national patterns of care in radiosurgery
with an eye toward improving health care outcomes, supporting
informed decision making and potentially lowering the cost-of-care
delivery to patients. Elekta's Gamma Knife Registry will be
utilized by participants to collect and provide data to the
national effort.
To learn more about Leksell Gamma Knife Registry, visit
www.elekta.com/LGKRegistry.
*Data, including protected health information, will be stored
in the United States.
For further information, please contact:
Gert van Santen, Group Vice President Corporate
Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Raven Canzeri, Global Public
Relations Manager, Elekta
Tel: +1 770-670-2524, e-mail: raven.canzeri@elekta.com
Time zone: ET: Eastern Time
About Elekta
Elekta is a human care company pioneering
significant innovations and clinical solutions for treating cancer
and brain disorders. The company develops sophisticated,
state-of-the-art tools and treatment planning systems for radiation
therapy, radiosurgery and brachytherapy, as well as workflow
enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer confidence
to both health care providers and patients, Elekta aims to improve,
prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in
over 6,000 hospitals worldwide. Elekta employs around 3,800
employees globally. The corporate headquarters is located in
Stockholm, Sweden, and the company
is listed on NASDAQ Stockholm. Website: www.elekta.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/elekta-to-showcase-leksell-gamma-knife-registry-at-aans-annual-meeting-300075799.html
SOURCE Elekta